Beckerman R - Search Results

1

A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen.

Watson C, Gadikota H, Barlev A, Beckerman R. Watson C, et al. Among authors: beckerman r. J Drug Assess. 2022 Jun 3;11(1):1-11. doi: 10.1080/21556660.2022.2073101. eCollection 2022. J Drug Assess. 2022. PMID: 35693477 Free PMC article.

2

Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients.

Watson C, Barlev A, Worrall J, Duff S, Beckerman R. Watson C, et al. Among authors: beckerman r. J Drug Assess. 2020 Dec 24;10(1):18-26. doi: 10.1080/21556660.2020.1854561. J Drug Assess. 2020. PMID: 33489434 Free PMC article.

3

Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.

Levy D, Craig T, Keith PK, Krishnarajah G, Beckerman R, Prusty S. Levy D, et al. Among authors: beckerman r. Allergy Asthma Clin Immunol. 2020 May 27;16:41. doi: 10.1186/s13223-020-00437-x. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32514272 Free PMC article.

4

Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States.

Ahmed A, Gonzalez SA, Cholankeril G, Perumpail RB, McGinnis J, Saab S, Beckerman R, Younossi ZM. Ahmed A, et al. Among authors: beckerman r. Hepatology. 2017 Jul;66(1):46-56. doi: 10.1002/hep.29137. Epub 2017 May 27. Hepatology. 2017. PMID: 28257591

5

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.

Younossi Z, Blissett D, Blissett R, Henry L, Younossi Y, Beckerman R, Hunt S. Younossi Z, et al. Among authors: beckerman r. Liver Int. 2018 Feb;38(2):258-265. doi: 10.1111/liv.13519. Epub 2017 Aug 24. Liver Int. 2018. PMID: 28719013

6

Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.

Beckerman R, Gori A, Jeyakumar S, Malin JJ, Paredes R, Póvoa P, Smith NJ, Teixeira-Pinto A. Beckerman R, et al. Sci Rep. 2022 Jun 10;12(1):9622. doi: 10.1038/s41598-022-13680-6. Sci Rep. 2022. PMID: 35688854 Free PMC article. Review.

7

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.

Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. Younossi ZM, et al. Among authors: beckerman r. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. Hepatology. 2016. PMID: 27543837

8

Reply.

Ahmed A, Beckerman R, Younossi ZM. Ahmed A, et al. Among authors: beckerman r. Hepatology. 2018 Jan;67(1):450-451. doi: 10.1002/hep.29555. Hepatology. 2018. PMID: 28960407 No abstract available.

9

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan.

Younossi ZM, Tanaka A, Eguchi Y, Henry L, Beckerman R, Mizokami M. Younossi ZM, et al. Among authors: beckerman r. J Viral Hepat. 2018 Aug;25(8):945-951. doi: 10.1111/jvh.12886. Epub 2018 Mar 14. J Viral Hepat. 2018. PMID: 29478258

10

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe.

Cacoub P, Buggisch P, Carrión JA, Cooke GS, Zignego AL, Beckerman R, Younossi Z. Cacoub P, et al. Among authors: beckerman r. J Viral Hepat. 2018 Jul;25(7):811-817. doi: 10.1111/jvh.12881. Epub 2018 Mar 30. J Viral Hepat. 2018. PMID: 29476572 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters